Uploaded and shared in Youtube by: OncUViewTV — Dr. Eric Baudin discusses results from the RADIANT 2 study as part of a continuing series, Headline News in NETS 2011. This program is supported by an un-restricted educational grant from Novartis Oncology and intended for non-US audiences only.
WHAT IS SYMPOSIER?
Symposier.com is the technological platform that will allow you (and your colleagues) to share medical information, event calendars, clinical cases, new procedures and much more with medicine professionals around the world.
Get in touch with medical professionals around the world and seize the collective experiences and knowledge to the benefit of your own patients.
Establish common-interest groups to build a collaboration network
Learn, comment and publish about local or international medical events
Seize and publish to our video, image and medical documents library
Symposier uploaded this video.
Does Treatment with Everolimus + Octreotide LAR Affect 5-HIAA Levels in Patients with Advanced NeuroEndocrine Tumors
Date: 18 May 2011
Uploader: Symposier
Lenght: 8m 51s
Specialty:
Endocrinology
Neurology
Oncology
Pharmacology
